Professional KAM does no longer "sell drugs".
Org-charts will be very different from today and will be centred around cross-functional collaboration.
Imagine how great it would be to end departmental fights and start looking what patients, HCPs, payers, researchers and all the other stakeholders really need!
By the way: Department comes from "depart" and does not even have a semantic link to collaboration!
There is no other place in the world where know-how and knowledge about specific diseases is so concentrated as in the respective pharmacetical company.
The value of sharing this knowledge and wisdom will be tremendous!